Foghorn Therapeutics

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FHTX and other ETFs, options, and stocks.

About FHTX

Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology.

CEO

Adrian Gottschalk

CEOAdrian Gottschalk

Employees

116

Employees116

Headquarters

Cambridge, Massachusetts

HeadquartersCambridge, Massachusetts

Founded

2015

Founded2015

Employees

116

Employees116

FHTX Key Statistics

Market cap

235.82M

Market cap235.82M

Price-Earnings ratio

-2.46

Price-Earnings ratio-2.46

Dividend yield

—

Dividend yield—

Average volume

83.30K

Average volume83.30K

High today

$5.83

High today$5.83

Low today

$5.50

Low today$5.50

Open price

$5.76

Open price$5.76

Volume

119.67K

Volume119.67K

52 Week high

$9.97

52 Week high$9.97

52 Week low

$2.70

52 Week low$2.70

Foghorn Therapeutics

Why Robinhood?

Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology. Show more

FHTX Key Statistics

Foghorn Therapeutics, Inc. operates as a development stage biopharmaceutical company. It is discovering and developing a novel class of precision medicine therapeutics targeting the chromatin regulatory system in oncology.